White Nights International Oncology Forum

Park Inn Pribaltiyskaya
St. Petersburg, Russia
2017, June 23-25

Sign up to meet GCT representatives at the meeting!

The Forum “White Nights” is one of the largest events in the field of oncology that unites a wide range of specialists from Russia, CIS and far-abroad countries; the main objective of the Forum is to consolidate the forces of the medical community to share the latest professional information in order to improve health care quality and reduce cancer incidence and mortality rates.

The 1st St. Petersburg Oncology Forum “White Nights” was held in 2015 and became a remarkable event for oncology professionals. The 2nd Forum “White Nights” was held on June 22-24, 2016. For the first time the Forum was preceded by pre-courses. Within two days, the Forum’s participants intensively gained experience in specialized workshops on onco-surgery, breast imaging and methodology of scientific research in oncology. Over 300 specialists attended the pre-Forum. The main focus was on the updated interactive presentation and discussion of contemporary approaches to oncology.

The Forum is attended by chemotherapists, specialists in radiation diagnostics and therapy (including radiologists, CT and MRI specialists, ultrasound medical investigation specialists), pathologists, geneticists, immunologists, mammologists, surgeons, endocrinologists, gynecologists, urologists, palliative care and rehabilitation practitioners, specialists of clinical diagnostic and molecular genetics laboratories, specialists of pharmaceutical companies and others.

http://forum-onco.ru/en/

About

GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login

 

GCT

© 2001—2018 Global Clinical Trials, LLC

All rights reserved.